lethal (with Ank2f00518)
NMJ bouton (with Ank2RM5-1)
Ank2f02001/Ank2f02001 mutant 1st, 2nd and 3rd instar larval neuromuscular junctions exhibit abberant microtubule organization, with aggregates of central microtubules; and a significant increase in synaptic retraction frequency at later larval stages, but no defect in the presence of microtubules at terminal boutons, as compared to controls.
Ank2f02001 mutants exhibit a significant increase in synaptic retractions compared with controls.
Sound-evoked compound action potentials in the antennal nerve are not significantly different from wild type in mutant flies. However, nonlinear mechanical amplification is significantly reduced compared to wild type.
Ank2f02001 mutant third instar larvae show severe NMJ degeneration, leading to complete elimination of the presynaptic nerve terminal at many NMJs. Loss of Ank2 also causes axonal blockages and severe disruption of the axonal and synaptic microtubule skeleton.
Homozygous egrΔ25 mutants show large defects in EPSP amplitude compared to wild-type. A large number of recording are seen that have average EPSPs below 25mV.
Neuromuscular junctions of mutant larvae have fewer but larger boutons than normal.
Neuromuscular junctions of Ank2RM5-1/Ank2f02001 larvae have fewer but larger boutons than normal. The synaptic span (the widest extension of synaptic branches along a muscle fibre) is reduced compared to wild type.
Homozygotes die at late larval/early pupal stages.
Homozygotes show severe synaptic retractions at more than 60% of all neuromuscular junctions (NMJs) on muscles 6/7.
Ank2f02001/Df(3L)RM5-2 and Ank2f02001/Ank2f00518 animals die as third instar larvae/early pupae, and they show severe synaptic retractions at the NMJs.
The severity of the synaptic retraction phenotype that is seen at the NMJs of Ank2f02001/Df(3L)RM5-2 animals increases progressively during larval development.
Ank2f02001/Df(3L)RM5-2 third instar larvae show defects in synaptic transmission and motoneuron excitability at the NMJ. Defects in in synapse morphology are also seen at the NMJ, with enlarged presynaptic membrane compartments. The presynaptic microtubule cytoskeleton shows abnormal organisation. Ultrastructurally, NMJs show hallmarks of synapse degeneration, including accumulations of endosomal/vacuole-like membrane profiles. In addition, giant synaptic boutons are seen at the NMJ. The boutons are elongated laterally, and multiple active zones can be detected. In addition, large vesicles are present. Large accumulations of microtubules can also be seen, with vesicles being absent from these regions.
Ank2f02001 has abnormal neurophysiology phenotype, suppressible | partially by Scer\GAL4elav-C155/wgnRNAi.UAS
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible by Dcp-1Prev1
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible | partially by Dcp-1[+]/Dcp-1Prev1
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible | partially by DebclE26
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible | partially by DarkCD4
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible | partially by egrΔ25
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible | partially by egrRNAi.UAS/Scer\GAL4egr-GAL4
Ank2f02001 has abnormal neuroanatomy phenotype, suppressible | partially by Scer\GAL4elav-C155/wgnRNAi.UAS
Ank2f02001 has abnormal neurophysiology phenotype, suppressible | partially by egrΔ25
Ank2f02001 has abnormal neuroanatomy phenotype, non-suppressible by dl1
Ank2f02001 has synapse phenotype, enhanceable by CkIIαLL05896
Ank2f02001 has neuromuscular junction phenotype, enhanceable by CkIIαLL05896
Ank2f02001 has synapse phenotype, enhanceable by Scer\GAL4elav-C155/CkIIαK66M.UAS.N.Tag:HA
Ank2f02001 has neuromuscular junction phenotype, enhanceable by Scer\GAL4elav-C155/CkIIαK66M.UAS.N.Tag:HA
Ank2f02001 has synapse phenotype, suppressible by Scer\GAL4elav-C155/CkIIαUAS.N.Tag:HA
Ank2f02001 has neuromuscular junction phenotype, suppressible by Scer\GAL4elav-C155/CkIIαUAS.N.Tag:HA
Ank2f02001 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible | partially by egrΔ25
Ank2f02001 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible | partially by egrRNAi.UAS/Scer\GAL4egr-GAL4
Ank2f02001 has embryonic/larval neuromuscular junction | third instar larval stage phenotype, suppressible | partially by Scer\GAL4elav-C155/wgnRNAi.UAS
Ank2f02001 has embryonic/larval neuromuscular junction phenotype, suppressible by Dcp-1Prev1
Ank2f02001 has embryonic/larval neuromuscular junction phenotype, suppressible | partially by Dcp-1[+]/Dcp-1Prev1
Ank2f02001 has embryonic/larval neuromuscular junction phenotype, suppressible | partially by DebclE26
Ank2f02001 has embryonic/larval neuromuscular junction phenotype, suppressible | partially by DarkCD4
Ank2f02001 has microtubule | third instar larval stage phenotype, non-suppressible by egrΔ25
Ank2f02001 has axon | third instar larval stage phenotype, non-suppressible by egrΔ25
Ank2f02001 has microtubule | third instar larval stage phenotype, non-suppressible by Scer\GAL4elav-C155/wgnRNAi.UAS
Ank2f02001 has axon | third instar larval stage phenotype, non-suppressible by Scer\GAL4elav-C155/wgnRNAi.UAS
Ank2f02001 has embryonic/larval neuromuscular junction phenotype, non-suppressible by dl1
Ank2f02001 is an enhancer of synapse phenotype of CkIIαLL05896
Ank2f02001 is an enhancer of neuromuscular junction phenotype of CkIIαLL05896
Presynaptic expression of CkIIαScer\UAS.N.T:Ivir\HA1 in Ank2f02001 homozygous mutants significantly alleviates the synaptic retraction phenotype.
Presynaptic expression of CkIIαK66M.Scer\UAS.N.T:Ivir\HA1 in Ank2f02001 homozygous mutants enhances the synaptic retraction phenotype.
Removal of one copy of CkIIαP1 in a Ank2f02001 homozygous background significantly increases the frequency of synaptic retractions.
Removal of one copy of Ank2f02001 in a CkIIαP1 homozygous background significantly increases the frequency of synaptic retractions.
egrΔ25 partially suppresses the NMJ degeneration seen in Ank2f02001 mutant third instar larvae. The axonal blockages and microtubule disruption are not suppressed.
egrΔ25 partially suppresses the synaptic transmission defects seen in Ank2f02001 mutants. A near complete rescue in the number of small EPSPs is seen, however average EPSP amplitude is not completely restored to wild type levels.
Expression of egrdsRNA.Scer\UAS under the control of Scer\GAL4egr-GAL4 partially suppresses the NMJ degeneration seen in Ank2f02001 mutant third instar larvae.
Expression of wgndsRNA.Scer\UAS under the control of Scer\GAL4elav-C155 partially suppresses the NMJ degeneration seen in Ank2f02001 mutant third instar larvae. The axonal blockages and microtubule disruption are not suppressed.
Expression of wgndsRNA.Scer\UAS under the control of Scer\GAL4elav-C155 partially suppresses the synaptic transmission defects seen in Ank2f02001 mutants. A near complete rescue in the number of small EPSPs is seen, however average EPSP amplitude is not completely restored to wild type levels.
Homozygous Dcp-1Prev1 suppresses the NMJ degeneration seen in Ank2f02001 mutants. One copy of Dcp-1Prev1 is also able to partially suppress the phenotype.
Homozygous dl1 does not suppress the NMJ degeneration seen in Ank2f02001 mutant larvae.
Homozygous debclE26 partially suppresses the NMJ degeneration seen in Ank2f02001 mutants.
Homozygous ArkCD4 partially suppresses the NMJ degeneration seen in Ank2f02001 mutants.
Df(3L)RM5-2/Ank2f02001 is not rescued by Scer\GAL4unspecified/Ank2S.UAS.Venus
Df(3L)RM5-2/Ank2f02001 is not rescued by Ank2L8.UAS.Venus/Scer\GAL4unspecified
Precise excision of the insertion reverts the neuromuscular junction phenotype.